Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
13.07
-0.11 (-0.83%)
At close: Aug 24, 2026, 4:00 PM EDT
13.07
0.00 (0.00%)
After-hours: Aug 24, 2026, 7:30 PM EDT
Korro Bio Market Cap
Korro Bio has a market cap or net worth of $192.46 million as of August 24, 2026. Its market cap has increased by 2.27% in one year.
Market Cap
192.46M
Enterprise Value
96.76M
1-Year Change
2.27%
Ranking
Category
Stock Price
$13.07
ChartMarket Cap Chart
Since November 6, 2023, Korro Bio's market cap has increased from $123.80M to $192.46M, an increase of 55.47%. That is a compound annual growth rate of 17.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 192.46M | 155.15% |
| Dec 31, 2025 | 75.43M | -78.85% |
| Dec 31, 2024 | 356.65M | -6.96% |
| Dec 29, 2023 | 383.31M | 209.63% |
| Nov 6, 2023 | 123.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 209.20M |
| Voyager Therapeutics | 208.88M |
| Satellos Bioscience | 208.17M |
| Corbus Pharmaceuticals Holdings | 200.76M |
| Oramed Pharmaceuticals | 200.08M |
| NervGen Pharma | 199.99M |
| Protalix BioTherapeutics | 191.76M |
| Nkarta | 190.52M |